Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2026.03.31
ag真人平台官方：关于开展以套期保值为目的的外汇衍生品交易的公告
2026.03.31
ag真人平台官方：关于董事会换届选举的公告
2026.03.31
ag真人平台官方：关于变更H股募集资金使用用途的公告
2026.03.31
ag真人平台官方：关于2026年度向银行申请授信额度暨提供担保的公告
2026.03.31
ag真人平台官方：关于2025年度利润分配预案的公告
2026.03.31
ag真人平台官方：关于2025年度计提资产减值准备的公告
2026.03.31
ag真人平台官方：第六届董事会第二十次会议决议公告
2026.03.31
ag真人平台官方：2025年年度审计报告
2026.03.31
ag真人平台官方：2025年年度报告摘要
2026.03.31
ag真人平台官方：2025年度内部控制评价报告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
